Status:
NOT_YET_RECRUITING
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
Lead Sponsor:
University Hospital, Brest
Conditions:
Giant Cell Arteritis
Eligibility:
All Genders
18+ years
Brief Summary
Ultrasound evaluation of the temporal and axillary arteries is currently well recognized in the field of giant cell arteritis (GCA), a disease primarily affecting medium- and large-caliber vessels. St...
Detailed Description
Prospective bicentric longitudinal study evaluating the association between ultrasound lesions and clinico-biological relapse in patients with giant cell arteritis. This is a non-interventional study...
Eligibility Criteria
Inclusion
- Major patient
- Patients meeting ACR 2022 criteria for giant cell arteritis.
- No opposition expressed
Exclusion
- Patients unable to understand the protocol, under guardianship or curatorship.
- Patients not affiliated to the French Social Security system.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06894602
Start Date
May 1 2025
End Date
May 1 2028
Last Update
April 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29200
2
Ch Quimper
Quimper, France, 29107